Alnylam director granted stock and options
Alnylam Pharmaceuticals director Colleen F. Reitan received new equity awards as part of her compensation.
Rhea-AI Filing Summary
Alnylam Pharmaceuticals director Colleen F. Reitan received new equity awards as part of her compensation. She was granted 671 restricted stock units, each representing one share of common stock, increasing her direct holdings to 1,446 common shares after the award.
She also received a stock option covering 1,441 common shares at an exercise price of $298.48 per share. Both the RSUs and the option vest in full on the earlier of the first anniversary of the grant date or her earlier retirement or resignation, if that occurs no more than 90 days before the first anniversary.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 2,112 shares
Grant/Award
2 txns
Insider
Reitan Colleen F
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,441 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 671 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,441 contracts (Direct);
Common Stock — 1,446 shares (Direct)
Footnotes (2)
- F1. These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
- F2. The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
Key Figures
RSU grant: 671 shares
Shares owned after grant: 1,446 shares
Stock option size: 1,441 shares
+3 more
6 metrics
RSU grant
671 shares
Restricted stock units granted to director on May 20, 2026
Shares owned after grant
1,446 shares
Total common stock held directly after RSU award
Stock option size
1,441 shares
Option covering common stock granted May 20, 2026
Option exercise price
$298.48/share
Conversion or exercise price for new stock option
Option expiration
May 20, 2036
Expiration date of stock option grant
Vesting schedule
1-year cliff
RSUs and option vest on first anniversary or qualifying retirement/resignation
Key Terms
restricted stock units (RSUs), Stock Option (Right to Buy), Second Amended and Restated 2018 Stock Incentive Plan, exercise price
4 terms
restricted stock units (RSUs) financial
"These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with underlying common stock shares."
Second Amended and Restated 2018 Stock Incentive Plan financial
"RSUs granted under the Second Amended and Restated 2018 Stock Incentive Plan."
exercise price financial
"conversion_or_exercise_price: 298.4800 for the stock option grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Colleen F. Reitan receive in this ALNY Form 4 filing?
Colleen F. Reitan received 671 restricted stock units and a stock option for 1,441 shares of Alnylam common stock. These equity awards were granted as compensation, not purchased in the open market.
What are the key terms of Colleen F. Reitan’s new ALNY stock option?
The new stock option covers 1,441 common shares with an exercise price of $298.48 per share. It is scheduled to vest in full on the earlier of the first anniversary of the grant date or qualifying retirement or resignation.
When do Colleen F. Reitan’s ALNY restricted stock units vest?
The 671 restricted stock units vest in full on the earlier of the first anniversary of the grant date or the date of her earlier retirement or resignation, provided that such retirement or resignation occurs no more than 90 days before that anniversary.
Are Colleen F. Reitan’s ALNY equity awards open-market purchases?
No. Both the 671 restricted stock units and the 1,441-share stock option are compensation grants. The Form 4 describes them as awards, not open-market buy or sell transactions involving Alnylam stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
